[Federal Register Volume 68, Number 100 (Friday, May 23, 2003)]
[Notices]
[Page 28230]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-12959]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices: Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following Federal Committee meeting.

    Name: Advisory Committee on Immunization Practices (ACIP).
    Times and Dates: 8:30 a.m.-6:30 p.m., June 18, 2003. 8 a.m.-3:45 
p.m., June 19, 2003.
    Place: Atlanta Marriott Century Center, 2000 Century Boulevard, 
NE., Atlanta, Georgia 30345-3377.
    Status: Open to the public, limited only by the space available.
    Purpose: The Committee is charged with advising the Director, 
CDC, on the appropriate uses of immunizing agents. In addition, 
under 42 U.S.C. 1396s, the Committee is mandated to establish and 
periodically review and, as appropriate, revise the list of vaccines 
for administration to vaccine-eligible children through the Vaccines 
for Children (VFC) program, along with schedules regarding the 
appropriate periodicity, dosage, and contraindications applicable to 
the vaccines.
    Matters to be Discussed: The Agenda will include a discussion on 
the smallpox vaccine update; adverse events following smallpox 
vaccine in the civilian vaccination program; update investigation of 
cardiac adverse events following smallpox vaccine; women with 
smallpox vaccine exposure; report from the smallpox vaccine safety 
working group; consideration for the timing of revaccination; update 
on smallpox vaccine 10day/21day survey of recipients; vaccinating 
cochlear implant recipients against vaccine-preventable causes of 
bacterial meningitis; impact of ACIP Recommendations on the use of 
PCV7 by pediatricians during the shortage; influenza update and live 
attenuated influenza vaccine recommendation; recommending the 
meningococcal vaccine for adolescents; progress on safe, disposable 
cartridge jet injectors for mass immunization campaigns; update on a 
project to increase public engagement in decision-making about 
vaccines; evaluation of thimersol containing vaccines in non-human 
primates; and Federal Advisory Stakeholder Engagement Survey 
Results.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Demetria Gardner, 
Epidemiology and Surveillance Division, National Immunization 
Program, CDC, 1600 Clifton Road, NE., Mailstop E-61, Atlanta, 
Georgia 30333, telephone 404/639-8096, fax 404/639-8616.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: May 16, 2003.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 03-12959 Filed 5-22-03; 8:45 am]
BILLING CODE 4163-18-P